Four-Year Data Confirm Anifrolumab Efficacy in Lupus

(MedPage Today) -- Systemic lupus erythematosus (SLE) patients in the registration trials for anifrolumab (Saphnelo) who were followed for 4 years showed sustained improvement in hematologic and serologic parameters, as well as clinical symptom...